MktsMarkets

Collegium Pharmaceutical, Inc.
NASDAQ: COLLKey statistics
COLL News
Stories mentioning COLL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 193,520 | 205,449 | 209,361 | 188,000 | 177,757 | 181,949 | 159,301 | 145,276 |
| Cost of Goods Sold | 76,274 | 77,071 | 80,190 | 79,616 | 80,433 | 83,661 | 62,507 | 54,470 |
| Gross Profit | 117,246 | 128,378 | 129,171 | 108,384 | 97,324 | 98,288 | 96,794 | 90,806 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 86,350 | 67,640 | 67,103 | 73,637 | 76,423 | 63,091 | 61,955 | 43,335 |
| Total Operating Expenses | 86,350 | 67,621 | 67,084 | 73,279 | 75,637 | 60,177 | 61,955 | 43,335 |
| Operating Income (Loss) | 30,896 | 60,757 | 62,087 | 35,105 | 21,687 | 38,111 | 34,839 | 47,471 |
| Interest Income | 3,116 | 2,383 | 2,225 | 3,280 | 4,397 | |||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 18,740 | 29,036 | 43,436 | 17,025 | 3,122 | 17,269 | 15,580 | 29,097 |
| Tax Provision | 4,244 | 12,073 | 11,929 | 5,042 | 705.00 | 4,733 | 6,245 | 9,491 |
| Net Income (Loss) | 14,496 | 16,963 | 31,507 | 11,983 | 2,417 | 12,536 | 9,335 | 19,606 |
| Earnings Per Share (Basic) | 0.45 | 0.54 | 1.00 | 0.38 | 0.08 | 0.39 | 0.29 | 0.60 |
| Earnings Per Share (Diluted) | 0.40 | 0.46 | 0.84 | 0.34 | 0.07 | 0.36 | 0.27 | 0.52 |
| Weighted Average Shares Outstanding (Basic) | 32,087 | 31,653 | 31,571 | 31,811 | 31,794 | 32,079 | 32,259 | 32,433 |
| Weighted Average Shares Outstanding (Diluted) | 40,066 | 40,076 | 39,440 | 39,076 | 32,840 | 40,110 | 40,163 | 40,384 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About COLL
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is a stock listed on the Nasdaq Stock Market under the ticker symbol COLL. It last traded at $24.21 (Nov 6, 2026, 4:00 PM ET), down 3.8% on the day. That gives Collegium Pharmaceutical a market capitalisation of $788.2M and a price-to-earnings ratio of 16.4.
Over the past 52 weeks COLL has traded between $21.43 and $50.79.
Revenue for the quarter ended Mar 31, 2026 was $193.5M; net income $14.5M. Revenue was up 8.9% from $177.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $193.5M | $14.5M | 7.5% |
| Dec 31, 2025 | $205.4M | $17.0M | 8.3% |
| Sep 30, 2025 | $209.4M | $31.5M | 15.0% |
| Jun 30, 2025 | $188.0M | $12.0M | 6.4% |
From Collegium Pharmaceutical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…